EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Plasma metabolites in early adulthood are associated with midlife cognitive performance and brain tissue integrity in the CARDIA study

Zsuzsanna Ament, Jelani Deajon‐Jackson, Amelia Demopoulos, Varun M. Bhave, Ana‐Lucia Garcia Guarniz, Ilya M. Nasrallah, Hemant K. Tiwari, M. Ryan Irvin, Venkatesh L. Murthy, Ravi Shah, Kristine Yaffe, R. Nick Bryan, W. Taylor Kimberly

Alzheimer's & Dementia · 2026-11 · 22 (11)

DOI: 10.1002/alz.71982 ↗
AbstractBibliografische Angaben

Abstract

Abstract INTRODUCTION Circulating plasma metabolites may serve as early indicators of midlife cognitive performance, but whether these associations are also reflected in midlife brain structure or white matter hyperintensity (WMH) burden remains unclear. METHODS In the Coronary Artery Risk Development in Young Adults (CARDIA) study, we examined 575 plasma metabolites in early adulthood (Year 7; age [mean ± SD] 32 ± 3.6 years, N = 1,736) in relation to brain magnetic resonance imaging (MRI) and cognitive performance 23 years later (Year 30; age [mean ± SD] 55 ± 3.6 years, N = 646). RESULTS Eleven metabolites were independently associated with cognition; five were also associated with total brain volume but none with WMH burden. In mediation analysis, total brain volume accounted for 8%–33% of metabolite–cognition associations. DISCUSSION Plasma metabolites measured in early adulthood are associated with midlife cognitive performance and a subset is also associated with total brain volume, whereas no associations were observed with WMH burden, highlighting early‐adult metabolic signatures as markers of midlife brain structural health.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →